Legacy Advisory Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$526K Sell
4,097
-259
-6% -$30.3K 0.37% 29
2026
Q1
$524K Buy
+4,356
New +$503K 0.4% 24
2025
Q2
Sell
-4,494
Closed -$403K 49
2025
Q1
$403K Buy
4,494
+926
+26% +$86.5K 0.34% 37
2024
Q4
$355K Hold
3,568
0.3% 43
2024
Q3
$405K Hold
3,568
0.35% 40
2024
Q2
$442K Hold
3,568
0.4% 35
2024
Q1
$471K Sell
3,568
-60
-2% -$7.39K 0.45% 32
2023
Q4
$396K Buy
+3,628
New +$377K 0.42% 32

Other funds holding MRK

Legacy Advisory Services's MRK Position: Q2 2026 in Review

Legacy Advisory Services reduced its Merck (MRK) stake by 5.9% in Q2 2026, selling an estimated $30.3K and leaving 4,097 shares worth $526K. The position accounts for 0.37% of the portfolio, ranked #29.

Legacy Advisory Services first reported a position in MRK in Q4 2023 and has held it in 8 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Legacy Advisory Services held 4,097 shares of Merck worth $526K as of Q2 2026.
  • Legacy Advisory Services sold 259 Merck shares in Q2 2026, an estimated $30.3K.
  • Merck made up 0.37% of Legacy Advisory Services's portfolio in Q2 2026, its #29 holding.
  • Legacy Advisory Services first reported a position in Merck in Q4 2023 and has held it in 8 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Legacy Advisory Services's 13F filing for Q2 2026, filed 21 Jul 2026.